gamma-Secretase: characterization and implication for Alzheimer disease therapy

Neurobiol Aging. 2002 Nov-Dec;23(6):1023-30. doi: 10.1016/s0197-4580(02)00126-4.

Abstract

gamma-Secretase is a membrane-bound protease that cleaves within the transmembrane region of amyloid precursor protein to generate the C-termini of the Abeta peptides which are believed to play a central role in the neuropathology of Alzheimer's disease. An in vitro gamma-secretase assay using a recombinant substrate C100Flag has been developed to facilitate the characterization and identification of this enigmatic protease. Biochemical studies establish that gamma-secretase activity is catalyzed by a PS1-containing macromolecular complex. Moreover, the fact that the photoreactive active gamma-secretase inhibitor directed to the active site labels PS1 suggests that PS1 contains the active site of the protease. Presenilin/gamma-secretase as a potential target for AD therapy and its role in regulated intramembrane proteolysis are discussed.

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism*
  • Amyloid Precursor Protein Secretases
  • Aspartic Acid Endopeptidases
  • Carbamates / pharmacology
  • Dipeptides / pharmacology
  • Endopeptidases / analysis
  • Endopeptidases / metabolism*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Humans
  • Immunoenzyme Techniques / methods*
  • In Vitro Techniques
  • Membrane Proteins / metabolism*
  • Presenilin-1
  • Presenilin-2
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Carbamates
  • Dipeptides
  • Enzyme Inhibitors
  • L 685458
  • Membrane Proteins
  • PSEN1 protein, human
  • PSEN2 protein, human
  • Presenilin-1
  • Presenilin-2
  • Amyloid Precursor Protein Secretases
  • Endopeptidases
  • Aspartic Acid Endopeptidases
  • BACE1 protein, human